T1	Condition 360 375	Crohn's Disease
T2	Condition-Name 360 375	Crohn's Disease
E1	Condition:T1 Name:T2
T3	Condition 407 422	bowel disorders
T4	Condition-Name 407 422	bowel disorders
E3	Condition:T3 Name:T4
T5	Procedure 926 939	minor surgery
T6	Procedure-Name 926 939	minor surgery
E5	Procedure:T5 Name:T6
T13	Condition 1087 1095	disorder
T14	Condition-Name 1087 1095	disorder
E13	Condition:T13 Name:T14 Temporality:E22
T15	Eq-Operator 255 256	≥
A1	Eq-Operator-Value T15 GTEQ
T16	Eq-Operator 270 271	≥
A2	Eq-Operator-Value T16 GTEQ
T17	Eq-Operator 1282 1283	≤
A3	Eq-Operator-Value T17 LTEQ
T18	Eq-Temporal-Unit 68 74	months
A4	Eq-Temporal-Unit-Value T18 month
T19	Eq-Temporal-Unit 273 278	weeks
A5	Eq-Temporal-Unit-Value T19 week
T20	Eq-Temporal-Unit 1286 1291	weeks
A6	Eq-Temporal-Unit-Value T20 week
T21	Eq-Unit 129 131	cm
T22	Eq-Value 66 67	3
T23	Eq-Value 126 128	15
T24	Eq-Value 256 259	2.4
T25	Eq-Value 271 272	4
T30	Eq-Value 1283 1285	12
T31	Eq-Comparison 255 265	≥2.4 g/day
E14	Eq-Comparison:T31 Operator:T15 Value:T24 Per:T69 Unit:T68
T32	Eq-Comparison 270 278	≥4 weeks
E15	Eq-Comparison:T32 Operator:T16 Temporal-Unit:T19 Value:T25
T33	Eq-Comparison 1282 1291	≤12 weeks
E16	Eq-Comparison:T33 Operator:T17 Temporal-Unit:T20 Value:T30
T34	Eq-Comparison 178 184	active
E17	Eq-Comparison:T34 Temporal-Period:T35
T35	Eq-Temporal-Period 178 184	active
A7	Eq-Temporal-Period-Value T35 present
T36	Eq-Comparison 832 848	History of prior
E18	Eq-Comparison:T36 Temporal-Period:T37
T37	Eq-Temporal-Period 832 848	History of prior
A8	Eq-Temporal-Period-Value T37 past
T40	Eq-Comparison 446 451	prior
E20	Eq-Comparison:T40 Temporal-Period:T41
T41	Eq-Temporal-Period 446 451	prior
A10	Eq-Temporal-Period-Value T41 past
T44	Eq-Comparison 946 951	Prior
E22	Eq-Comparison:T44 Temporal-Period:T45
T45	Eq-Temporal-Period 946 951	Prior
A12	Eq-Temporal-Period-Value T45 past
T48	Condition 50 52	UC
E2	Condition:T48 Name:T49 Temporality:E4
T49	Condition-Name 50 52	UC
T50	Eq-Comparison 57 74	at least 3 months
E4	Eq-Comparison:T50 Operator:T51 Value:T22 Temporal-Unit:T18
T51	Eq-Operator 57 65	at least
A14	Eq-Operator-Value T51 GTEQ
T38	Study 84 93	screening
E6	Study:T38 
T39	Temporal-Connection 75 83	prior to
E8	Temporal-Connection:T39 Arg:E4 Arg2:E6
A9	Temporal-Connection-Type-Value E8 before
T52	Observation 100 122	minimum disease extent
E10	Observation:T52 Name:T53 Eq-Comparison:E12
T53	Observation-Name 100 122	minimum disease extent
A15	Observation-Type-Value T53 measurement
T54	Eq-Comparison 126 131	15 cm
E12	Eq-Comparison:T54 Value:T23 Unit:T21
T55	And 95 99	with
E19	And:T55 Arg:E6 Arg2:E10
T56	Modifier 141 151	anal verge
E24	Modifier:T56 Modifies:E10
T57	Condition 185 187	UC
E25	Condition:T57 Name:T58 Temporality:E17 Severity:T61
T58	Condition-Name 185 187	UC
T59	Eq-Comparison 157 177	Mildly to moderately
E26	Eq-Comparison:T59 Value:T60 Value2:T61
T60	Severity 157 163	Mildly
A16	Severity-Value T60 mild
T61	Severity 167 177	moderately
A17	Severity-Value T61 moderate
T62	Eq-Comparison 216 223	ongoing
E27	Eq-Comparison:T62 Temporal-Period:T63
T63	Eq-Temporal-Period 216 223	ongoing
A18	Eq-Temporal-Period-Value T63 present
T64	Procedure 224 233	treatment
E28	Procedure:T64 Temporality:E27
T65	Modifier 193 212	Inadequate response
E29	Modifier:T65 Modifies:E28
T66	Drug 239 254	oral mesalamine
E30	Drug:T66 Name:T67 Dose:E14 Duration:E15
T67	Drug-Name 239 254	oral mesalamine
R2	Using Arg1:E28 Arg2:E30	
T68	Eq-Unit 260 261	g
T69	Eq-Temporal-Unit 262 265	day
A19	Eq-Temporal-Unit-Value T69 day
T70	Study 284 293	screening
E31	Study:T70 
T71	Temporal-Connection 279 283	from
E32	Temporal-Connection:T71 Arg:E15 Arg2:E31
A20	Temporal-Connection-Type-Value E32 after
T72	Assertion 325 333	Possible
E33	Assertion:T72 Asserted:E1
A21	Assertion-Type-Value E33 possible
T73	Modifier 394 406	inflammatory
E34	Modifier:T73 Modifies:T4
T74	Other 379 384	other
E35	Other:T74 Is-Other:E3
T75	Or 376 378	or
E36	Or:T75 Arg:E1 Arg2:E3
T76	Eq-Comparison 428 435	Ongoing
E37	Eq-Comparison:T76 Temporal-Period:T77
T77	Eq-Temporal-Period 428 435	Ongoing
A22	Eq-Temporal-Period-Value T77 present
T78	Modifier 439 445	failed
E38	Modifier:T78 Modifies:E40
T79	Condition 466 468	UC
E39	Condition:T79 Name:T80
T80	Condition-Name 466 468	UC
T81	Procedure 452 461	treatment
E40	Procedure:T81 Temporality:E20 Temporality2:E37
T82	Or 436 438	or
E41	Or:T82 Arg:E37 Arg2:E20
R3	Treatment-For Arg1:E40 Arg2:E39	
T83	Drug 474 486	methotrexate
E42	Drug:T83 Name:T84
T84	Drug-Name 474 486	methotrexate
R4	Using Arg1:E40 Arg2:E42	
T85	Drug 488 500	azathioprine
E43	Drug:T85 Name:T86
T86	Drug-Name 488 500	azathioprine
R5	Using Arg1:E40 Arg2:E43	
T26	Drug 507 523	6-mercaptopurine
E44	Drug:T26 Name:T87
T87	Drug-Name 507 523	6-mercaptopurine
T88	Drug 525 537	cyclosporine
E45	Drug:T88 Name:T89
T89	Drug-Name 525 537	cyclosporine
T90	Drug 539 550	tofacitinib
E46	Drug:T90 Name:T91
T91	Drug-Name 539 550	tofacitinib
T92	Drug 552 573	mycophenolate mofetil
E47	Drug:T92 Name:T93
T93	Drug-Name 552 573	mycophenolate mofetil
T94	Drug 575 584	sirolimus
E48	Drug:T94 Name:T95
T95	Drug-Name 575 584	sirolimus
T96	Drug 586 595	rapamycin
E49	Drug:T96 Name:T97
T97	Drug-Name 586 595	rapamycin
R6	Equivalent-To Arg1:E49 Arg2:E48	
T98	Drug 598 609	thalidomide
E50	Drug:T98 Name:T99
T99	Drug-Name 598 609	thalidomide
T100	Drug 611 621	tacrolimus
E51	Drug:T100 Name:T101
T101	Drug-Name 611 621	tacrolimus
T27	Drug 623 629	FK-506
E52	Drug:T27 Name:T102
T102	Drug-Name 623 629	FK-506
T103	Drug 635 644	biologics
E53	Drug:T103 Name:T104
T104	Drug-Name 635 644	biologics
T105	Or 632 634	or
E54	Or:T105 Arg:E52 Arg2:E53
T106	Drug 652 673	TNF-alpha-antagonists
E55	Drug:T106 Name:T107
T107	Drug-Name 652 673	TNF-alpha-antagonists
R7	Example-Of Arg1:E55 Arg2:E53	
T9	Drug 675 698	anti-integrin therapies
E9	Drug:T9 Name:T10
T10	Drug-Name 675 698	anti-integrin therapies
T28	Drug 703 719	agents targeting
E56	Drug:T28 Name:T29
T29	Drug-Name 703 719	agents targeting
T108	Modifier 720 725	IL-12
E57	Modifier:T108 Modifies:T29
T109	Modifier 729 734	IL-23
E58	Modifier:T109 Modifies:T29
T110	Or 726 728	or
E59	Or:T110 Arg:E57 Arg2:E58
R8	Example-Of Arg1:E56 Arg2:E53	
R9	Example-Of Arg1:E9 Arg2:E53	
T111	Or 700 702	or
E60	Or:T111 Arg:E9 Arg2:E56
R10	Using Arg1:E40 Arg2:E44	
R11	Using Arg1:E40 Arg2:E45	
R12	Using Arg1:E40 Arg2:E46	
R13	Using Arg1:E40 Arg2:E47	
R14	Using Arg1:E40 Arg2:E48	
R15	Using Arg1:E40 Arg2:E50	
R16	Using Arg1:E40 Arg2:E51	
R17	Using Arg1:E40 Arg2:E53	
R18	Equivalent-To Arg1:E52 Arg2:E51	
T112	Condition 751 778	immunosuppressive condition
E61	Condition:T112 Name:T113
T113	Condition-Name 751 778	immunosuppressive condition
T114	Drug 797 826	immunosuppressive medications
E62	Drug:T114 Name:T115
T115	Drug-Name 797 826	immunosuppressive medications
T116	Procedure 782 791	treatment
E63	Procedure:T116 
T117	Or 779 781	or
E64	Or:T117 Arg:E61 Arg2:E63
R19	Using Arg1:E63 Arg2:E62	
T118	Procedure 849 870	surgical intervention
E65	Procedure:T118 Name:T119 Temporality:E18
T119	Procedure-Name 849 870	surgical intervention
T42	Modifier 892 914	gastrointestinal tract
E21	Modifier:T42 Modifies:T119
T43	Exception 916 925	excluding
E66	Exception:T43 From:E65 Except:E5
T120	Modifier 1071 1086	immune-mediated
E67	Modifier:T120 Modifies:T14
T121	Modifier 1050 1067	neuro-psychiatric
E68	Modifier:T121 Modifies:T14
T122	Modifier 1039 1048	oncologic
E69	Modifier:T122 Modifies:T14
T123	Modifier 1024 1037	hematological
E70	Modifier:T123 Modifies:T14
T7	Modifier 1012 1022	infectious
E7	Modifier:T7 Modifies:T14
T8	Modifier 1001 1010	endocrine
E11	Modifier:T8 Modifies:T14
T11	Modifier 992 999	hepatic
E71	Modifier:T11 Modifies:T14
T12	Modifier 985 990	renal
E72	Modifier:T12 Modifies:T14
T124	Modifier 969 983	cardiovascular
E73	Modifier:T124 Modifies:T14
T125	Or 1068 1070	or
E74	Or:T125 Arg:E68 Arg2:E67
T126	Study 1222 1229	results
E75	Study:T126 Stability:T127
T127	Stability 1154 1160	impact
A11	Stability-Value T127 change
T128	Assertion 1148 1153	might
E76	Assertion:T128 Asserted:T127
A23	Assertion-Type-Value E76 hypothetical
R20	Caused-By Arg1:T127 Arg2:E13	
T129	Drug 1276 1281	drugs
E77	Drug:T129 Temporality:E16
T130	Study 1260 1275	investigational
E78	Study:T130 Study-Of:E77
T131	Procedure 1235 1244	Treatment
E79	Procedure:T131 
R21	Using Arg1:E79 Arg2:E77	
T132	Other 1254 1259	other
E80	Other:T132 Is-Other:E78
T46	Study 1301 1309	baseline
E23	Study:T46 
T47	Temporal-Connection 1292 1300	prior to
E81	Temporal-Connection:T47 Arg:E16 Arg2:E23
A13	Temporal-Connection-Type-Value E81 before
T133	Condition 1343 1352	condition
E82	Condition:T133 
T134	Risk 1461 1465	risk
E83	Risk:T134 Severity:T135
T135	Severity 1449 1460	significant
A24	Severity-Value T135 severe
R22	Caused-By Arg1:E83 Arg2:E82	
T136	Study 1484 1489	study
E84	Study:T136 Stability:T137
T137	Stability 1471 1479	confound
A25	Stability-Value T137 change
T138	Assertion 1467 1470	may
E85	Assertion:T138 Asserted:T137
A26	Assertion-Type-Value E85 hypothetical
R23	Caused-By Arg1:T137 Arg2:E82	
T139	Study 1574 1579	study
E86	Study:T139 Stability:T140
T140	Stability 1506 1515	interfere
A27	Stability-Value T140 change
T141	Assertion 1502 1505	may
E87	Assertion:T141 Asserted:T140
A28	Assertion-Type-Value E87 hypothetical
R24	Caused-By Arg1:T140 Arg2:E82	
T142	Or 1499 1501	or
E88	Or:T142 Arg:E84 Arg2:E87
